The Orphan Drug Act provides for granting special status to a drug or biological product| U.S. Food and Drug Administration
Fast Track| U.S. Food and Drug Administration
Drug and Biologic Accelerated Approvals Based on a Surrogate Endpoint| U.S. Food and Drug Administration